{"transactions":[{"id":759326,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restriced Stock Unit","published_at":"2026-05-29T22:05:11.000Z","date":"2026-05-27","kind":"grant","planned":false,"acquired":true,"shares":2567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 27, 2027."}],"balance_after":2567,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2567},"source":{"system":"sec-edgar","filing":"0001126490-26-000005","document":"wk-form4_1780092309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000112649026000005/wk-form4_1780092309.xml","form_type":"4"}},{"id":768855,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T23:23:29.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3318},"source":{"system":"sec-edgar","filing":"0001126490-26-000003","document":"wk-form4_1779405806.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000112649026000003/wk-form4_1779405806.xml","form_type":"4"}},{"id":768854,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T23:23:29.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37798,"source":{"system":"sec-edgar","filing":"0001126490-26-000003","document":"wk-form4_1779405806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000112649026000003/wk-form4_1779405806.xml","form_type":"4"}},{"id":775865,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2026-05-18T21:50:38.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted May 20, 2016 and vested in 12 equal monthly installments beginning June 20, 2016.  These options will expire ten years from the date of grant on May 20, 2026."}],"balance_after":0,"derivative":{"exercise_price":47.89,"expiration_date":"2026-05-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000914475-26-000027","document":"wk-form4_1779141036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000027/wk-form4_1779141036.xml","form_type":"4"}},{"id":775864,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T21:50:38.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":157.6507,"value":2364760.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted and effective on February 13, 2026. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $155.51 to $158.68. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":34480,"source":{"system":"sec-edgar","filing":"0000914475-26-000027","document":"wk-form4_1779141036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000027/wk-form4_1779141036.xml","form_type":"4"}},{"id":775863,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T21:50:38.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":47.89,"value":718350.0,"ownership":{"direct":true},"balance_after":49480,"source":{"system":"sec-edgar","filing":"0000914475-26-000027","document":"wk-form4_1779141036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447526000027/wk-form4_1779141036.xml","form_type":"4"}},{"id":862621,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2026-03-05T01:20:22.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":88843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition."}],"balance_after":88843,"derivative":{"underlying":"Ordinary Shares","underlying_shares":88843},"source":{"system":"sec-edgar","filing":"0001520262-26-000062","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000152026226000062/form4.xml","form_type":"4"}},{"id":916382,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2026-02-07T00:14:03.000Z","date":"2026-02-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":62230,"price":33.55,"value":2087816.5,"ownership":{"direct":true},"balance_after":1377740,"source":{"system":"sec-edgar","filing":"0001520262-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000152026226000019/form4.xml","form_type":"4"}},{"id":916381,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2026-02-07T00:14:03.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":149580,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 23, 2023 with a three-year performance period that ended on December 31, 2025 (the \"2023 PRSUs\"). The vesting of this portion of the 2023 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a relative total shareholder return modifier and represents the final vesting event under the 2023 PRSUs."}],"balance_after":1439970,"source":{"system":"sec-edgar","filing":"0001520262-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000152026226000019/form4.xml","form_type":"4"}},{"id":1138140,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:23:40.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":2869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2869},"source":{"system":"sec-edgar","filing":"0000914475-25-000129","document":"wk-form4_1747949013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000129/wk-form4_1747949013.xml","form_type":"4"}},{"id":1138139,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-22T21:23:40.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":3318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 21, 2026."}],"balance_after":3318,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3318},"source":{"system":"sec-edgar","filing":"0000914475-25-000129","document":"wk-form4_1747949013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000129/wk-form4_1747949013.xml","form_type":"4"}},{"id":1138138,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-22T21:23:40.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":true,"shares":2869,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34480,"source":{"system":"sec-edgar","filing":"0000914475-25-000129","document":"wk-form4_1747949013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447525000129/wk-form4_1747949013.xml","form_type":"4"}},{"id":1256486,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-20T22:11:39.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":293921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026."}],"balance_after":293921,"derivative":{"exercise_price":35.84,"expiration_date":"2035-02-19","underlying":"Ordinary Shares","underlying_shares":293921},"source":{"system":"sec-edgar","filing":"0001127602-25-006030","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760225006030/form4.xml","form_type":"4"}},{"id":1279058,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2025-02-08T01:36:49.000Z","date":"2025-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":79925,"price":31.39,"value":2508845.75,"ownership":{"direct":true},"balance_after":1290390,"source":{"system":"sec-edgar","filing":"0001127602-25-003685","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760225003685/form4.xml","form_type":"4"}},{"id":1279057,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2025-02-08T01:36:49.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":190640,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 18, 2022 with a three-year performance period that ended on December 31, 2024 (the \"2022 PRSUs\"). The vesting of this portion of the 2022 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a total shareholder return modifier and represents the final vesting event under the 2022 PRSUs."}],"balance_after":1370315,"source":{"system":"sec-edgar","filing":"0001127602-25-003685","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760225003685/form4.xml","form_type":"4"}},{"id":1504411,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-23T22:26:06.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":2869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest in full on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest in full on May 22, 2025."}],"balance_after":2869,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2869},"source":{"system":"sec-edgar","filing":"0000914475-24-000150","document":"wk-form4_1716503150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000150/wk-form4_1716503150.xml","form_type":"4"}},{"id":1507791,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-05-21T21:27:46.000Z","date":"2024-05-17","kind":"exercise","planned":true,"acquired":false,"shares":4199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Restricted Stock Unit (\"RSU\") represents the right to receive one share of the Issuer's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This RSU award was granted to the Reporting Person on May 17, 2023 and is fully vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4199},"source":{"system":"sec-edgar","filing":"0000914475-24-000136","document":"wk-form4_1716326835.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000136/wk-form4_1716326835.xml","form_type":"4"}},{"id":1507790,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T21:27:46.000Z","date":"2024-05-17","kind":"sale","planned":true,"acquired":false,"shares":2100,"price":141.8383,"value":297860.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.80 to $142.71. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range"}],"balance_after":31611,"source":{"system":"sec-edgar","filing":"0000914475-24-000136","document":"wk-form4_1716326835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000136/wk-form4_1716326835.xml","form_type":"4"}},{"id":1507789,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-21T21:27:46.000Z","date":"2024-05-17","kind":"exercise","planned":true,"acquired":true,"shares":4199,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33711,"source":{"system":"sec-edgar","filing":"0000914475-24-000136","document":"wk-form4_1716326835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000136/wk-form4_1716326835.xml","form_type":"4"}},{"id":1575525,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-15T21:19:38.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":false,"shares":23200,"price":42.76,"value":992032.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025."}],"balance_after":0,"derivative":{"exercise_price":42.76,"expiration_date":"2025-05-28","underlying":"Common Stock","underlying_shares":23200},"source":{"system":"sec-edgar","filing":"0000914475-24-000092","document":"wk-form4_1710537566.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000092/wk-form4_1710537566.xml","form_type":"4"}},{"id":1575524,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-15T21:19:38.000Z","date":"2024-03-13","kind":"sale","planned":true,"acquired":false,"shares":23200,"price":140.3285,"value":3255621.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.77.  The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0000914475-24-000092","document":"wk-form4_1710537566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000092/wk-form4_1710537566.xml","form_type":"4"}},{"id":1575523,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-15T21:19:38.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":true,"shares":23200,"price":42.76,"value":992032.0,"ownership":{"direct":true},"balance_after":52712,"source":{"system":"sec-edgar","filing":"0000914475-24-000092","document":"wk-form4_1710537566.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000092/wk-form4_1710537566.xml","form_type":"4"}},{"id":1582285,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-12T22:47:46.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":false,"shares":100,"price":42.76,"value":4276.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025."}],"balance_after":23200,"derivative":{"exercise_price":42.76,"expiration_date":"2025-05-28","underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0000914475-24-000088","document":"wk-form4_1710283649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000088/wk-form4_1710283649.xml","form_type":"4"}},{"id":1582284,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-03-12T22:47:46.000Z","date":"2024-03-08","kind":"exercise","planned":true,"acquired":false,"shares":1700,"price":42.76,"value":72692.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted May 28, 2015 and vested in 12 equal monthly installments beginning June 28, 2015. These options will expire ten years from the date of grant on May 28, 2025."}],"balance_after":23300,"derivative":{"exercise_price":42.76,"expiration_date":"2025-05-28","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0000914475-24-000088","document":"wk-form4_1710283649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000088/wk-form4_1710283649.xml","form_type":"4"}},{"id":1582283,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T22:47:46.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":100,"price":140,"value":14000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0000914475-24-000088","document":"wk-form4_1710283649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000088/wk-form4_1710283649.xml","form_type":"4"}},{"id":1582282,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T22:47:46.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":true,"shares":100,"price":42.76,"value":4276.0,"ownership":{"direct":true},"balance_after":29612,"source":{"system":"sec-edgar","filing":"0000914475-24-000088","document":"wk-form4_1710283649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000088/wk-form4_1710283649.xml","form_type":"4"}},{"id":1582281,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T22:47:46.000Z","date":"2024-03-08","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":140.0459,"value":238078.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.13. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0000914475-24-000088","document":"wk-form4_1710283649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000088/wk-form4_1710283649.xml","form_type":"4"}},{"id":1582280,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T22:47:46.000Z","date":"2024-03-08","kind":"exercise","planned":true,"acquired":true,"shares":1700,"price":42.76,"value":72692.0,"ownership":{"direct":true},"balance_after":31212,"source":{"system":"sec-edgar","filing":"0000914475-24-000088","document":"wk-form4_1710283649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000088/wk-form4_1710283649.xml","form_type":"4"}},{"id":1616540,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":274328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/26/2025."}],"balance_after":274328,"derivative":{"exercise_price":30.04,"expiration_date":"2034-02-26","underlying":"Ordinary Shares","underlying_shares":274328},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616539,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":5697,"price":26.82,"value":152793.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024."}],"balance_after":290570,"derivative":{"exercise_price":26.82,"expiration_date":"2033-02-23","underlying":"Ordinary Shares","underlying_shares":5697},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616538,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":5980,"price":24.59,"value":147048.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023."}],"balance_after":305024,"derivative":{"exercise_price":24.59,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":5980},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616537,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":6843,"price":19.34,"value":132343.62,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022."}],"balance_after":349030,"derivative":{"exercise_price":19.34,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":6843},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616536,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":7168,"price":20.03,"value":143575.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Shares subject to the stock option award vest and become exercisable in four equal annual installments commencing on 2/20/2021."}],"balance_after":365634,"derivative":{"exercise_price":20.03,"expiration_date":"2030-02-20","underlying":"Ordinary Shares","underlying_shares":7168},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616535,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":7644,"price":31.93,"value":244072.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares underlying the stock option award shall not vest and become exercisable unless and until the closing price of an ordinary share of Alkermes plc, as reported by the Nasdaq Global Select Market or another national securities exchange on which Alkermes plc's ordinary shares are listed, is fifty U.S. Dollars (US$50.00) or higher for thirty (30) consecutive trading days during the term of the award (the \"performance criteria\").  Subject to achievement of the performance criteria, the shares underlying the stock option award shall vest in four equal annual installments commencing on 2/21/2020. This award expires ten years from the date of grant."}],"balance_after":389844,"derivative":{"exercise_price":31.93,"expiration_date":"2029-02-21","underlying":"Ordinary Shares","underlying_shares":7644},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616534,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":2419,"price":31.93,"value":77238.67,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":123419,"derivative":{"exercise_price":31.93,"expiration_date":"2029-02-21","underlying":"Ordinary Shares","underlying_shares":2419},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616533,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":5899,"price":65.94,"value":388980.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":300899,"derivative":{"exercise_price":65.94,"expiration_date":"2028-02-16","underlying":"Ordinary Shares","underlying_shares":5899},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616532,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":3999,"price":53.5,"value":213946.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":203999,"derivative":{"exercise_price":53.5,"expiration_date":"2027-02-17","underlying":"Ordinary Shares","underlying_shares":3999},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616531,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":5999,"price":31.64,"value":189808.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":305999,"derivative":{"exercise_price":31.64,"expiration_date":"2026-02-28","underlying":"Ordinary Shares","underlying_shares":5999},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616530,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":3999,"price":69.83,"value":279250.17,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":203999,"derivative":{"exercise_price":69.83,"expiration_date":"2025-02-26","underlying":"Ordinary Shares","underlying_shares":3999},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1616529,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-27T21:02:12.000Z","date":"2023-11-17","kind":"other","planned":false,"acquired":true,"shares":4599,"price":46.24,"value":212657.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the \"Separation\"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are fully vested in accordance with their terms."}],"balance_after":234599,"derivative":{"exercise_price":46.24,"expiration_date":"2024-03-03","underlying":"Ordinary Shares","underlying_shares":4599},"source":{"system":"sec-edgar","filing":"0001127602-24-007137","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224007137/form4.xml","form_type":"4"}},{"id":1626598,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2024-02-22T22:11:49.000Z","date":"2024-02-20","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted May 22, 2014 and vested in 12 equal monthly installments beginning June 22, 2014. These options will expire ten years from the date of grant on May 22, 2024."}],"balance_after":0,"derivative":{"exercise_price":12.98,"expiration_date":"2024-05-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000914475-24-000078","document":"wk-form4_1708639891.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000078/wk-form4_1708639891.xml","form_type":"4"}},{"id":1626597,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-22T22:11:49.000Z","date":"2024-02-20","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":132.4698,"value":1987047.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on November 21, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.64 to $134.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0000914475-24-000078","document":"wk-form4_1708639891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000078/wk-form4_1708639891.xml","form_type":"4"}},{"id":1626596,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-22T22:11:49.000Z","date":"2024-02-20","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"balance_after":44512,"source":{"system":"sec-edgar","filing":"0000914475-24-000078","document":"wk-form4_1708639891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000091447524000078/wk-form4_1708639891.xml","form_type":"4"}},{"id":1649722,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2024-02-13T03:00:05.000Z","date":"2024-02-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":91757,"price":26.77,"value":2456334.89,"ownership":{"direct":true},"balance_after":1179675,"source":{"system":"sec-edgar","filing":"0001127602-24-004634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224004634/form4.xml","form_type":"4"}},{"id":1649721,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2024-02-13T03:00:05.000Z","date":"2024-02-08","kind":"grant","planned":false,"acquired":true,"shares":218551,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 22, 2021 with a three-year performance period that ended on December 31, 2023 (the \"2021 PRSUs\"). The vesting of this portion of the 2021 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a total shareholder return modifier and represents the final vesting event under the 2021 PRSUs."}],"balance_after":1271432,"source":{"system":"sec-edgar","filing":"0001127602-24-004634","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760224004634/form4.xml","form_type":"4"}},{"id":1885693,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-05-19T21:20:47.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Restricted Stock Units will vest in full on May 17, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Restricted Stock Units will vest in full on May 17, 2024."}],"balance_after":4199,"derivative":{"underlying":"Common Stock","underlying_shares":4199},"source":{"system":"sec-edgar","filing":"0001209191-23-031115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123031115/doc4.xml","form_type":"4"}},{"id":1993784,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-25T01:26:49.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":284873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024."}],"balance_after":284873,"derivative":{"exercise_price":27.36,"expiration_date":"2033-02-23","underlying":"Ordinary Shares","underlying_shares":284873},"source":{"system":"sec-edgar","filing":"0001127602-23-007184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760223007184/form4.xml","form_type":"4"}},{"id":2000481,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2023-02-22T22:00:31.000Z","date":"2023-02-21","kind":"exercise","acquired":false,"shares":32400,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":32400},"source":{"system":"sec-edgar","filing":"0001127602-23-006518","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760223006518/form4.xml","form_type":"4"}},{"id":2000480,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2023-02-22T22:00:31.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":14386,"price":27.77,"value":399499.22,"ownership":{"direct":true},"balance_after":1052881,"source":{"system":"sec-edgar","filing":"0001127602-23-006518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760223006518/form4.xml","form_type":"4"}},{"id":2000479,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2023-02-22T22:00:31.000Z","date":"2023-02-21","kind":"exercise","acquired":true,"shares":32400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one ordinary share."}],"balance_after":1067267,"source":{"system":"sec-edgar","filing":"0001127602-23-006518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760223006518/form4.xml","form_type":"4"}},{"id":2000478,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2023-02-22T22:00:31.000Z","date":"2023-02-20","kind":"tax_withholding","acquired":false,"shares":53145,"price":28.07,"value":1491780.15,"ownership":{"direct":true},"balance_after":1034867,"source":{"system":"sec-edgar","filing":"0001127602-23-006518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760223006518/form4.xml","form_type":"4"}},{"id":2000477,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2023-02-22T22:00:31.000Z","date":"2023-02-20","kind":"grant","acquired":true,"shares":119713,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These ordinary shares were acquired by the reporting person as a result of the vesting of performance-vesting restricted stock unit awards granted to the reporting person on February 20, 2020 with a three-year performance period that ended on December 31, 2022 (the \"2020 PRSUs\"). The vesting of this portion of the 2020 PRSUs was triggered by the determination of achievement of certain pre-specified performance goals and application of a total shareholder return modifier and represents the final vesting event under the 2020 PRSUs."}],"balance_after":1088012,"source":{"system":"sec-edgar","filing":"0001127602-23-006518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760223006518/form4.xml","form_type":"4"}},{"id":2064045,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2023-01-05T23:18:25.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":15000,"price":12.71,"value":190650.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option granted May 23, 2013 and vested monthly over one year."}],"balance_after":0,"derivative":{"exercise_price":12.71,"expiration_date":"2023-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-002053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002053/doc4.xml","form_type":"4"}},{"id":2064044,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:18:25.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":15000,"price":119.203,"value":1788045.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $117.79 to $120.43. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0001209191-23-002053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002053/doc4.xml","form_type":"4"}},{"id":2064043,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T23:18:25.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":15000,"price":12.71,"value":190650.0,"ownership":{"direct":true},"balance_after":44512,"source":{"system":"sec-edgar","filing":"0001209191-23-002053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919123002053/doc4.xml","form_type":"4"}},{"id":2262527,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-05-20T20:11:12.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":9724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 monthly installments beginning June 18, 2022."}],"balance_after":9724,"derivative":{"exercise_price":84.95,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":9724},"source":{"system":"sec-edgar","filing":"0001209191-22-030984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122030984/doc4.xml","form_type":"4"}},{"id":2275345,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-05-11T21:36:26.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":7500,"price":6.66,"value":49950.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted May 23, 2012 and vested monthly over one year."}],"balance_after":0,"derivative":{"exercise_price":6.66,"expiration_date":"2022-05-23","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-22-028369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122028369/doc4.xml","form_type":"4"}},{"id":2275344,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2022-05-11T21:36:26.000Z","date":"2022-05-09","kind":"exercise","acquired":false,"shares":7500,"price":6.66,"value":49950.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option granted May 23, 2012 and vested monthly over one year."}],"balance_after":7500,"derivative":{"exercise_price":6.66,"expiration_date":"2022-05-23","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-22-028369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122028369/doc4.xml","form_type":"4"}},{"id":2275343,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:36:26.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":7500,"price":76.3002,"value":572251.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $75.57 to $78.55. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0001209191-22-028369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122028369/doc4.xml","form_type":"4"}},{"id":2275342,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:36:26.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":7500,"price":6.66,"value":49950.0,"ownership":{"direct":true},"balance_after":37012,"source":{"system":"sec-edgar","filing":"0001209191-22-028369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122028369/doc4.xml","form_type":"4"}},{"id":2275341,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:36:26.000Z","date":"2022-05-09","kind":"sale","acquired":false,"shares":7500,"price":76.2948,"value":572211.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $75.54 to $78.55. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":29512,"source":{"system":"sec-edgar","filing":"0001209191-22-028369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122028369/doc4.xml","form_type":"4"}},{"id":2275340,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T21:36:26.000Z","date":"2022-05-09","kind":"exercise","acquired":true,"shares":7500,"price":6.66,"value":49950.0,"ownership":{"direct":true},"balance_after":37012,"source":{"system":"sec-edgar","filing":"0001209191-22-028369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919122028369/doc4.xml","form_type":"4"}},{"id":2279574,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-05-06T21:04:19.000Z","date":"2022-05-06","kind":"exercise","acquired":false,"shares":120847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":16.55,"expiration_date":"2022-05-21","underlying":"Ordinary Shares","underlying_shares":120847},"source":{"system":"sec-edgar","filing":"0001127602-22-013707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222013707/form4.xml","form_type":"4"}},{"id":2279573,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-05-06T21:04:19.000Z","date":"2022-05-05","kind":"exercise","acquired":false,"shares":329153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options are fully vested in accordance with their terms."}],"balance_after":120847,"derivative":{"exercise_price":16.55,"expiration_date":"2022-05-21","underlying":"Ordinary Shares","underlying_shares":329153},"source":{"system":"sec-edgar","filing":"0001127602-22-013707","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222013707/form4.xml","form_type":"4"}},{"id":2279572,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-05-06T21:04:19.000Z","date":"2022-05-06","kind":"sale","acquired":false,"shares":93747,"price":27.8549,"value":2611313.3103,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made to cover the option exercise price and related fees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.36 to $28.32. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":968299,"source":{"system":"sec-edgar","filing":"0001127602-22-013707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222013707/form4.xml","form_type":"4"}},{"id":2279571,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-05-06T21:04:19.000Z","date":"2022-05-06","kind":"exercise","acquired":true,"shares":120847,"price":16.55,"value":2000017.85,"ownership":{"direct":true},"balance_after":1062046,"source":{"system":"sec-edgar","filing":"0001127602-22-013707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222013707/form4.xml","form_type":"4"}},{"id":2279570,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-05-06T21:04:19.000Z","date":"2022-05-05","kind":"sale","acquired":false,"shares":32288,"price":28.5935,"value":923226.928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made to cover the option exercise price and related fees."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.44 to $28.82. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":941199,"source":{"system":"sec-edgar","filing":"0001127602-22-013707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222013707/form4.xml","form_type":"4"}},{"id":2279569,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-05-06T21:04:19.000Z","date":"2022-05-05","kind":"sale","acquired":false,"shares":221222,"price":27.9504,"value":6183243.3888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made to cover the option exercise price and related fees."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.44 to $28.43. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":973487,"source":{"system":"sec-edgar","filing":"0001127602-22-013707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222013707/form4.xml","form_type":"4"}},{"id":2279568,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-05-06T21:04:19.000Z","date":"2022-05-05","kind":"exercise","acquired":true,"shares":329153,"price":16.55,"value":5447482.15,"ownership":{"direct":true},"balance_after":1194709,"source":{"system":"sec-edgar","filing":"0001127602-22-013707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222013707/form4.xml","form_type":"4"}},{"id":2379246,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2022-02-23T21:37:38.000Z","date":"2022-02-21","kind":"exercise","acquired":false,"shares":32400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into ordinary shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020."}],"balance_after":32400,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":32400},"source":{"system":"sec-edgar","filing":"0001127602-22-006324","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222006324/form4.xml","form_type":"4"}},{"id":2379245,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-23T21:37:38.000Z","date":"2022-02-18","kind":"grant","acquired":true,"shares":299044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023."}],"balance_after":299044,"derivative":{"exercise_price":25.08,"expiration_date":"2032-02-18","underlying":"Ordinary Shares","underlying_shares":299044},"source":{"system":"sec-edgar","filing":"0001127602-22-006324","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222006324/form4.xml","form_type":"4"}},{"id":2379244,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-02-23T21:37:38.000Z","date":"2022-02-21","kind":"tax_withholding","acquired":false,"shares":14386,"price":25.08,"value":360800.88,"ownership":{"direct":true},"balance_after":865556,"source":{"system":"sec-edgar","filing":"0001127602-22-006324","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222006324/form4.xml","form_type":"4"}},{"id":2379243,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-02-23T21:37:38.000Z","date":"2022-02-21","kind":"exercise","acquired":true,"shares":32400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into ordinary shares on a one-for-one basis."}],"balance_after":879942,"source":{"system":"sec-edgar","filing":"0001127602-22-006324","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222006324/form4.xml","form_type":"4"}},{"id":2389072,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2022-02-17T21:21:56.000Z","date":"2022-02-16","kind":"exercise","acquired":false,"shares":18125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into ordinary shares on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award is fully vested in accordance with its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award is fully vested in accordance with its terms."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":18125},"source":{"system":"sec-edgar","filing":"0001127602-22-005452","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222005452/form4.xml","form_type":"4"}},{"id":2389071,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-02-17T21:21:56.000Z","date":"2022-02-16","kind":"tax_withholding","acquired":false,"shares":8038,"price":26.79,"value":215338.02,"ownership":{"direct":true},"balance_after":847542,"source":{"system":"sec-edgar","filing":"0001127602-22-005452","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222005452/form4.xml","form_type":"4"}},{"id":2389070,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2022-02-17T21:21:56.000Z","date":"2022-02-16","kind":"exercise","acquired":true,"shares":18125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into ordinary shares on a one-for-one basis."}],"balance_after":855580,"source":{"system":"sec-edgar","filing":"0001127602-22-005452","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760222005452/form4.xml","form_type":"4"}},{"id":2568126,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-09-16T20:32:26.000Z","date":"2021-09-14","kind":"tax_withholding","acquired":false,"shares":36267,"price":30.6,"value":1109770.2,"ownership":{"direct":true},"balance_after":837455,"source":{"system":"sec-edgar","filing":"0001127602-21-025409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221025409/form4.xml","form_type":"4"}},{"id":2568125,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-09-16T20:32:26.000Z","date":"2021-09-14","kind":"grant","acquired":true,"shares":81682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These ordinary shares were acquired by the reporting person as a result of the partial vesting of performance-vesting restricted stock unit awards (\"PRSUs\") granted to the reporting person on February 20, 2020. The vesting of this portion of the PRSUs was triggered by the achievement of certain pre-specified pipeline performance goals."}],"balance_after":873722,"source":{"system":"sec-edgar","filing":"0001127602-21-025409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221025409/form4.xml","form_type":"4"}},{"id":2703966,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2021-05-20T20:09:52.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":8833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in 12 equal monthly installments beginning June 19, 2021."}],"balance_after":8833,"derivative":{"exercise_price":92.35,"exercise_date":"2021-06-19","expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":8833},"source":{"system":"sec-edgar","filing":"0001209191-21-034386","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919121034386/doc4.xml","form_type":"4"}},{"id":2705904,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-19T20:27:27.000Z","date":"2021-05-18","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":0,"derivative":{"exercise_price":18.105,"expiration_date":"2021-05-20","underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001127602-21-017397","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221017397/form4.xml","form_type":"4"}},{"id":2705903,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-05-19T20:27:27.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":150000,"price":21.9027,"value":3285405.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.76 to $22.05. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":792040,"source":{"system":"sec-edgar","filing":"0001127602-21-017397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221017397/form4.xml","form_type":"4"}},{"id":2705902,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-05-19T20:27:27.000Z","date":"2021-05-18","kind":"exercise","acquired":true,"shares":150000,"price":18.105,"value":2715750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":942040,"source":{"system":"sec-edgar","filing":"0001127602-21-017397","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221017397/form4.xml","form_type":"4"}},{"id":2716876,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-12T20:24:30.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options are fully vested in accordance with their terms."}],"balance_after":150000,"derivative":{"exercise_price":18.105,"expiration_date":"2021-05-20","underlying":"Ordinary Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001127602-21-016394","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221016394/form4.xml","form_type":"4"}},{"id":2716875,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-05-12T20:24:30.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":60297,"price":22.3029,"value":1344797.9613,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.25 to $22.38. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":792040,"source":{"system":"sec-edgar","filing":"0001127602-21-016394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221016394/form4.xml","form_type":"4"}},{"id":2716874,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-05-12T20:24:30.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":89703,"price":21.9451,"value":1968541.3053,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.25 to $22.24. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":852337,"source":{"system":"sec-edgar","filing":"0001127602-21-016394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221016394/form4.xml","form_type":"4"}},{"id":2716873,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-05-12T20:24:30.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":150000,"price":18.105,"value":2715750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":942040,"source":{"system":"sec-edgar","filing":"0001127602-21-016394","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221016394/form4.xml","form_type":"4"}},{"id":2723527,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-07T20:47:37.000Z","date":"2021-05-06","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested in accordance with their terms."}],"balance_after":300000,"derivative":{"exercise_price":18.105,"expiration_date":"2021-05-20","underlying":"Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001127602-21-015894","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221015894/form4.xml","form_type":"4"}},{"id":2723526,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-05-07T20:47:37.000Z","date":"2021-05-06","kind":"sale","acquired":false,"shares":100000,"price":21.7941,"value":2179410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.54 to $22.16. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request."}],"balance_after":792040,"source":{"system":"sec-edgar","filing":"0001127602-21-015894","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221015894/form4.xml","form_type":"4"}},{"id":2723525,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-05-07T20:47:37.000Z","date":"2021-05-06","kind":"exercise","acquired":true,"shares":100000,"price":18.105,"value":1810500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":892040,"source":{"system":"sec-edgar","filing":"0001127602-21-015894","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221015894/form4.xml","form_type":"4"}},{"id":2836290,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-25T01:59:32.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":342187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022."}],"balance_after":342187,"derivative":{"exercise_price":19.73,"expiration_date":"2031-02-22","underlying":"Ordinary Shares","underlying_shares":342187},"source":{"system":"sec-edgar","filing":"0001127602-21-007797","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221007797/form4.xml","form_type":"4"}},{"id":2839992,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2021-02-24T02:37:55.000Z","date":"2021-02-21","kind":"exercise","acquired":false,"shares":32400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/21/2020."}],"balance_after":64800,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":32400},"source":{"system":"sec-edgar","filing":"0001127602-21-007462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221007462/form4.xml","form_type":"4"}},{"id":2839991,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-02-24T02:37:55.000Z","date":"2021-02-21","kind":"tax_withholding","acquired":false,"shares":14386,"price":19.58,"value":281677.88,"ownership":{"direct":true},"balance_after":792040,"source":{"system":"sec-edgar","filing":"0001127602-21-007462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221007462/form4.xml","form_type":"4"}},{"id":2839990,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-02-24T02:37:55.000Z","date":"2021-02-21","kind":"exercise","acquired":true,"shares":32400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":806426,"source":{"system":"sec-edgar","filing":"0001127602-21-007462","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221007462/form4.xml","form_type":"4"}},{"id":2851026,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2021-02-19T00:28:09.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/17/2018."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001127602-21-006566","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221006566/form4.xml","form_type":"4"}},{"id":2851025,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Restricted Stock Unit Award","published_at":"2021-02-19T00:28:09.000Z","date":"2021-02-16","kind":"exercise","acquired":false,"shares":18125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/16/2019."}],"balance_after":18125,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":18125},"source":{"system":"sec-edgar","filing":"0001127602-21-006566","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221006566/form4.xml","form_type":"4"}},{"id":2851024,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:28:09.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":3869,"price":19.97,"value":77263.93,"ownership":{"direct":true},"balance_after":774026,"source":{"system":"sec-edgar","filing":"0001127602-21-006566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221006566/form4.xml","form_type":"4"}},{"id":2851023,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:28:09.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":777895,"source":{"system":"sec-edgar","filing":"0001127602-21-006566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221006566/form4.xml","form_type":"4"}},{"id":2851022,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:28:09.000Z","date":"2021-02-16","kind":"tax_withholding","acquired":false,"shares":8074,"price":19.79,"value":159784.46,"ownership":{"direct":true},"balance_after":769145,"source":{"system":"sec-edgar","filing":"0001127602-21-006566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221006566/form4.xml","form_type":"4"}},{"id":2851021,"issuer":{"id":2392,"kind":"organization","name":"Alkermes plc.","symbol":"ALKS"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":true,"officer_title":"Director and CEO, Alkermes plc"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:28:09.000Z","date":"2021-02-16","kind":"exercise","acquired":true,"shares":18125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":777219,"source":{"system":"sec-edgar","filing":"0001127602-21-006566","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000112760221006566/form4.xml","form_type":"4"}},{"id":3127518,"issuer":{"id":12703,"kind":"organization","name":"Epizyme, Inc.","symbol":"EPZM"},"owners":[{"id":43292,"kind":"person","name":"POPS RICHARD F","position":1,"cik":"0001126490","reported_name":"POPS RICHARD F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T20:15:55.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":14013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in full on May 29, 2021, subject to Reporting Person's continued service as a director.  In the event of a change in control of the Issuer, the option will become exercisable in full."}],"balance_after":14013,"derivative":{"exercise_price":17.55,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":14013},"source":{"system":"sec-edgar","filing":"0000899243-20-014897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1126490/000089924320014897/doc4.xml","form_type":"4"}}],"next_cursor":"2020-06-02T20:15:55.000000Z,3127518"}